These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35986542)

  • 21. Current Insights into the Chemistry and Antitubercular Potential of Benzimidazole and Imidazole Derivatives.
    Parwani D; Bhattacharya S; Rathore A; Mallick C; Asati V; Agarwal S; Rajoriya V; Das R; Kashaw SK
    Mini Rev Med Chem; 2021; 21(5):643-657. PubMed ID: 33138762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pyrazinamide resistance in Mycobacterium tuberculosis: Review and update.
    Njire M; Tan Y; Mugweru J; Wang C; Guo J; Yew W; Tan S; Zhang T
    Adv Med Sci; 2016 Mar; 61(1):63-71. PubMed ID: 26521205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis.
    Rangnekar B; Momin MAM; Eedara BB; Sinha S; Das SC
    Int J Pharm; 2019 Oct; 570():118689. PubMed ID: 31513868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delamanid Kills Dormant Mycobacteria
    Chen X; Hashizume H; Tomishige T; Nakamura I; Matsuba M; Fujiwara M; Kitamoto R; Hanaki E; Ohba Y; Matsumoto M
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
    Das R; Mehta DK
    Drug Res (Stuttg); 2021 Jan; 71(1):26-35. PubMed ID: 33027823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delamanid, linezolid, levofloxacin, and pyrazinamide for the treatment of patients with fluoroquinolone-sensitive multidrug-resistant tuberculosis (Treatment Shortening of MDR-TB Using Existing and New Drugs, MDR-END): study protocol for a phase II/III, multicenter, randomized, open-label clinical trial.
    Lee M; Mok J; Kim DK; Shim TS; Koh WJ; Jeon D; Lee T; Lee SH; Kim JS; Park JS; Lee JY; Kim SY; Lee JH; Jo KW; Jhun BW; Kang YA; Ahn JH; Kim CK; Shin S; Song T; Shin SJ; Kim YR; Ahn H; Hahn S; Won HJ; Jang JY; Cho SN; Yim JJ
    Trials; 2019 Jan; 20(1):57. PubMed ID: 30651149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of pyrazinamide resistance across the spectrum of drug resistant phenotypes of Mycobacterium tuberculosis.
    Whitfield MG; Streicher EM; Dolby T; Simpson JA; Sampson SL; Van Helden PD; Van Rie A; Warren RM
    Tuberculosis (Edinb); 2016 Jul; 99():128-130. PubMed ID: 27450014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of pyrazinamide resistance in consecutive multidrug-resistant
    Mansjo M; Werngren J; Hoffner S
    Int J Mycobacteriol; 2017; 6(2):156-161. PubMed ID: 28559517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Investigation of pyrazinamide resistance in multidrug-resistant tuberculosis cases in Hospital of Pulmonary Diseases, Izmir, Turkey].
    Senol G; Coşkun M; Gündüz AT; Biçmen C; Gayaf M; Ozsöz A
    Mikrobiyol Bul; 2008 Oct; 42(4):591-7. PubMed ID: 19149080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing treatment outcome of first-line anti-tuberculosis drugs: the role of therapeutic drug monitoring.
    Verbeeck RK; Günther G; Kibuule D; Hunter C; Rennie TW
    Eur J Clin Pharmacol; 2016 Aug; 72(8):905-16. PubMed ID: 27305904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pyrazinamide Susceptibility and
    Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Refining MDR-TB treatment regimens for ultra short therapy (TB-TRUST): study protocol for a randomized controlled trial.
    Weng T; Sun F; Li Y; Chen J; Chen X; Li R; Ge S; Zhao Y; Zhang W
    BMC Infect Dis; 2021 Feb; 21(1):183. PubMed ID: 33596848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug resistance in Mycobacterium tuberculosis: molecular mechanisms challenging fluoroquinolones and pyrazinamide effectiveness.
    Miotto P; Cirillo DM; Migliori GB
    Chest; 2015 Apr; 147(4):1135-1143. PubMed ID: 25846529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis and biological activity of pyrazinamide derivatives for anti-Mycobacterium tuberculosis.
    Zhou S; Yang S; Huang G
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1183-1186. PubMed ID: 28870094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of pyrazinamidase structural changes in pyrazinamide resistant and susceptible isolates of Mycobacterium tuberculosis.
    Ahmady A; Poolad T; Rafee P; Tousheh M; Kahbazi M; Arjomandzadegan M
    Tuberk Toraks; 2013; 61(2):110-4. PubMed ID: 23875588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis.
    Fofana MO; Shrestha S; Knight GM; Cohen T; White RG; Cobelens F; Dowdy DW
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27956422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activity of 5-chloro-pyrazinamide in mice infected with Mycobacterium tuberculosis or Mycobacterium bovis.
    Ahmad Z; Tyagi S; Minkowsk A; Almeida D; Nuermberger EL; Peck KM; Welch JT; Baughn AS; Jacobs WR; Grosset JH
    Indian J Med Res; 2012 Nov; 136(5):808-14. PubMed ID: 23287128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.